Role of transfusion-transmitted virus in acute viral hepatitis and fulminant hepatic failure of unknown etiology.
OBJECTIVE
The role of the newly described transfusion-transmitted virus (TTV), a circular single-stranded DNA virus, has been investigated in acute liver disease, comprising 36 patients with acute viral hepatitis (AVH) and 25 with fulminant hepatic failure (FHF), including 50 volunteer blood donors as controls.


METHODS
Detection of TTV DNA sequences was carried out by polymerase chain reaction (PCR) using primers derived from the UTR(A) region of the TTV genome. The clinical course and biochemical profile when infected with TTV alone or coinfected with other classical hepatotropic viruses were analyzed. All patients were first evaluated for liver function profile and for the presence of various hepatotropic viruses using serological tests and PCR in serologically negative patients.


RESULTS
Transfusion-transmitted virus DNA was detected in 80.6% (29/36) of the AVH cases and in 76% (19/25) of the FHF cases, which were significantly higher levels (P < 0.05) than the 52% (26/50) observed in volunteer blood donors. No significant difference in symptoms, clinical course, liver function and risk factor profile between TTV-positive and TTV-negative patients could be observed in both AVH and FHF patients. TTV was found to coexist with both parenterally and non-parenterally transmitted hepatotropic viruses in similar frequency in both AVH and FHF patients. Further, there was no significant difference in the mortality rates between TTV-positive and TTV-negative FHF patients. Also, there was no difference between patients coinfected by TTV and other hepatotropic viruses and those with TTV infection alone.


CONCLUSIONS
Thus, it appears that TTV, although it exists in a very high frequency in the Indian population, appears to have no significant etiological role in AVH and FHF.
Das
Kunal
K
Gastroenterology Division, Department of Medicine, Institute of Cytology and Molecular Oncology, Maulana Azad Medical College, New Delhi, India.
Kar
P
P
Gupta
R K
RK
Das
B C
BC
D000208:Acute Disease; D000328:Adult; D016022:Case-Control Studies; D004266:DNA Virus Infections / Q000150:complications*; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006506:Hepatitis A / Q000150:complications / Q000453:epidemiology; D006509:Hepatitis B / Q000150:complications / Q000453:epidemiology; D016751:Hepatitis E / Q000150:complications / Q000453:epidemiology; D006525:Hepatitis, Viral, Human / Q000821:virology*; D006801:Humans; D017093:Liver Failure / Q000821:virology*; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D015995:Prevalence; D022783:Torque teno virus / Q000235:genetics
D004279:DNA, Viral